HoloMD Secures $1.6M Seed Funding to Accelerate AI‑Powered Psychiatry Platform

Why It Matters

The funding underscores rising investor confidence in AI‑driven mental‑health technologies and could accelerate the adoption of remote therapeutic monitoring, potentially improving psychiatric outcomes while lowering costs for providers and payers.

Deal Summary

Rockville‑based HoloMD announced the close of the first tranche of its seed round, raising $1.6 million to expand its AI‑driven remote therapeutic monitoring platform for psychiatry. The undisclosed investors will help accelerate development of Dr. Holo, an AI companion that supports clinicians between visits. The funding aims to boost product rollout and market adoption.